Avanos Medical Inc.
AVNS | NYSE
$24.99
+$0.01 (+0.04%)
At close: Jul 24, 2026, 4:03 PM ET
Company Profile
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Key Executives
| Name | Position |
|---|---|
| David C. Pacitti | Chief Executive Officer & Director |
| Scott Michael Galovan | Chief Financial Officer & Senior Vice President |
| Siobhan Smyth | Vice President & Chief Information Officer |
| Jamie Handler | Vice President of Global Marketing |
| Jason Pickett | Vice President of Corporate Finance & Treasurer |
| John Joseph Hurley | Principal Accounting Officer & Controller |
| John S. Fischer | Vice President, Head of Legal & Secretary |
| Jonathan Turner | Vice President and Chief Ethics & Compliance Officer |
| Katrine Kubis | Vice President of Corporate Communications & Community Relations |
| Sigfrido Delgado | Senior Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2026 | S-8 POS | Filing |
| Jul 31, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 30, 2026 | 8-K | Current Report |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
| Jul 28, 2026 | 4 | Filing |
Avanos Medical Inc.
| Country | United States |
| IPO Date | Oct 20, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 2,287 |
| CEO | David C. Pacitti |
Contact Details
5405 Windward Parkway Alpharetta,
Georgia 30004 United States
Stock Details
| Ticker Symbol | AVNS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001606498 |
| CUSIP Number | 05350V106 |
| ISIN Number | US05350V1061 |
| SIC Code | 3842 |
Recent News
- 2 months ago / prnewswire.comKrystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
- 3 months ago / gurufocus.comAvanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
- 3 months ago / zacks.comReasons to Retain Avanos Medical Stock in Your Portfolio for Now
- 3 months ago / prnewswire.comAre AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
- 4 months ago / zacks.comAvanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
- 4 months ago / zacks.comNew Strong Sell Stocks for May 15th
- 4 months ago / zacks.comDeciphering Avanos Medical (AVNS) International Revenue Trends
- 5 months ago / zacks.comAVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
- 5 months ago / zacks.comAvanos Medical (AVNS) Lags Q1 Earnings Estimates
- 5 months ago / prnewswire.comAvanos Medical, Inc. Announces First Quarter 2026 Results
Add to Watchlist
Select watchlists to add or remove AVNS